Related Experiment Video
Updated: Jan 4, 2026

Author Spotlight: Understanding Retinal Vessel Resilience and Disease Progression
Published on: January 12, 2024
Systematic spatiotemporal mapping reveals divergent cell death pathways in three mouse models of hereditary retinal
Michael J Power1,2,3, Luke E Rogerson1,2,3,4,5, Timm Schubert1,2
1Institute for Ophthalmic Research, University of Tübingen, Tübingen, Germany.
Abstract:
Calcium (Ca2+ ) dysregulation has been linked to neuronal cell death, including in hereditary retinal degeneration. Ca2+ dysregulation is thought to cause rod and cone photoreceptor cell death. Spatial and temporal heterogeneities in retinal disease models have hampered validation of this hypothesis. We examined the role of Ca2+ in photoreceptor degeneration, assessing the activation pattern of Ca2+ -dependent calpain proteases, generating spatiotemporal maps of the entire retina in the cpfl1 mouse model for primary cone degeneration, and in the rd1 and rd10 models for primary rod degeneration. We used Gaussian process models to distinguish the temporal sequences of degenerative molecular processes from other variability sources.In the rd1 and rd10 models, spatiotemporal pattern of increased calpain activity matched the progression of primary rod degeneration. High calpain activity coincided with activation of the calpain-2 isoform but not with calpain-1, suggesting differential roles for both calpain isoforms. Primary rod loss was linked to upregulation of apoptosis-inducing factor, although only a minute fraction of cells showed activity of the apoptotic marker caspase-3. After primary rod degeneration concluded, caspase-3 activation appeared in cones, suggesting apoptosis as the dominant mechanism for secondary cone loss. Gaussian process models highlighted calpain activity as a key event during primary rod photoreceptor cell death. Our data suggest a causal link between Ca2+ dysregulation and primary, nonapoptotic degeneration of photoreceptors and a role for apoptosis in secondary degeneration of cones, highlighting the importance of the spatial and temporal location of key molecular events, which may guide the evaluation of new therapies.
Insights
Calcium dysregulation causes photoreceptor cell death in hereditary retinal degeneration. This study links calpain activity to primary rod degeneration and apoptosis to secondary cone loss, guiding new therapy development.
Area of Science:
- Neuroscience
- Ophthalmology
- Cell Biology
Background:
- Calcium (Ca2+) dysregulation is implicated in neuronal cell death, particularly in hereditary retinal degeneration.
- Photoreceptor cell death, affecting both rods and cones, is a hallmark of these conditions.
- Previous studies faced challenges in validating the role of Ca2+ due to spatial and temporal complexities in disease models.
Purpose of the Study:
- To investigate the role of Ca2+ in photoreceptor degeneration.
- To map the spatiotemporal activation patterns of Ca2+-dependent calpain proteases in retinal degeneration models.
- To differentiate temporal sequences of molecular events from other variability using Gaussian process models.
Main Methods:
- Generation of spatiotemporal maps of retinal degeneration in cpfl1, rd1, and rd10 mouse models.
- Assessment of Ca2+-dependent calpain protease activation patterns.
- Application of Gaussian process models to analyze temporal molecular sequences.
Main Results:
- Spatiotemporal patterns of increased calpain activity correlated with primary rod degeneration in rd1 and rd10 models.
- High calpain activity was linked to the calpain-2 isoform, not calpain-1, suggesting distinct roles.
- Apoptosis-inducing factor was upregulated during primary rod loss, with caspase-3 activation primarily observed in cones during secondary degeneration.
Conclusions:
- Ca2+ dysregulation is causally linked to primary, non-apoptotic photoreceptor degeneration.
- Apoptosis plays a significant role in the secondary degeneration of cone cells.
- Understanding the spatiotemporal dynamics of molecular events is crucial for developing effective therapies for retinal degeneration.

